These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 31064817)
21. Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients. Escate R; Padró T; Pérez de Isla L; Fuentes F; Alonso R; Mata P; Badimon L Atherosclerosis; 2024 May; 392():117502. PubMed ID: 38513437 [TBL] [Abstract][Full Text] [Related]
22. Circulating level of microRNA-142-5p is a potential biomarker for predicting in-stent restenosis: a case-control study. Pan CH; Chien SC; Chen CJ; Shih CM; Hsieh MH; Huang CY; Bi WF; Chan CS; Kao YT; Hsiao CY; Chiang SJ; Chiang KH; Huang JH; Liu YR; Luo JD; Huang HY; Wu CH BMC Cardiovasc Disord; 2021 Feb; 21(1):77. PubMed ID: 33557763 [TBL] [Abstract][Full Text] [Related]
23. The relationship of plasma miR-503 and coronary collateral circulation in patients with coronary artery disease. Fei Y; Hou J; Xuan W; Zhang C; Meng X Life Sci; 2018 Aug; 207():145-151. PubMed ID: 29870767 [TBL] [Abstract][Full Text] [Related]
24. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis. Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H Front Immunol; 2018; 9():3099. PubMed ID: 30687316 [TBL] [Abstract][Full Text] [Related]
25. Associations of Circulating microRNA-221 and 222 With the Severity of Coronary Artery Lesions in Acute Coronary Syndrome Patients. Yu X; Xu JF; Song M; Zhang L; Li YH; Han L; Tang MX; Zhang W; Zhong M; Wang ZH Angiology; 2022 Jul; 73(6):579-587. PubMed ID: 34330158 [TBL] [Abstract][Full Text] [Related]
26. Plasma Levels of microRNA-145 Are Associated with Severity of Coronary Artery Disease. Gao H; Guddeti RR; Matsuzawa Y; Liu LP; Su LX; Guo D; Nie SP; Du J; Zhang M PLoS One; 2015; 10(5):e0123477. PubMed ID: 25938589 [TBL] [Abstract][Full Text] [Related]
27. Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease. Kumar D; Narang R; Sreenivas V; Rastogi V; Bhatia J; Saluja D; Srivastava K Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32033332 [TBL] [Abstract][Full Text] [Related]
28. Circulating MiR-146a May be a Potential Biomarker of Coronary Heart Disease in Patients with Subclinical Hypothyroidism. Quan X; Ji Y; Zhang C; Guo X; Zhang Y; Jia S; Ma W; Fan Y; Wang C Cell Physiol Biochem; 2018; 45(1):226-236. PubMed ID: 29357324 [TBL] [Abstract][Full Text] [Related]
29. Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin-angiotensin system blockade. Satoh M; Takahashi Y; Tabuchi T; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M Clin Sci (Lond); 2015 Apr; 128(8):483-91. PubMed ID: 25385173 [TBL] [Abstract][Full Text] [Related]
30. Associations between circulating full-length angiopoietin-like protein 8 levels and severity of coronary artery disease in Chinese non-diabetic patients: a case-control study. Jiao X; He J; Yang Y; Yang S; Li J; Qin Y Cardiovasc Diabetol; 2018 Jun; 17(1):92. PubMed ID: 29940978 [TBL] [Abstract][Full Text] [Related]
31. microRNA-155 is inversely associated with severity of coronary stenotic lesions calculated by the Gensini score. Zhu GF; Yang LX; Guo RW; Liu H; Shi YK; Ye JS; Yang ZH Coron Artery Dis; 2014 Jun; 25(4):304-10. PubMed ID: 24525789 [TBL] [Abstract][Full Text] [Related]
32. Plasma miR-208b and miR-499: Potential Biomarkers for Severity of Coronary Artery Disease. Wang W; Li T; Gao L; Li Y; Sun Y; Yao HC Dis Markers; 2019; 2019():9842427. PubMed ID: 31885748 [TBL] [Abstract][Full Text] [Related]
33. [The value of circulating microRNA-1 in the early diagnosis of coronary atherosclerotic plaque rupture in patients with stable coronary heart disease]. Su T; Shao X; Yang L; Zhang X; Yang C Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 May; 33(5):568-572. PubMed ID: 34112294 [TBL] [Abstract][Full Text] [Related]
34. Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease. Kaur A; Mackin ST; Schlosser K; Wong FL; Elharram M; Delles C; Stewart DJ; Dayan N; Landry T; Pilote L Cardiovasc Res; 2020 May; 116(6):1113-1124. PubMed ID: 31782762 [TBL] [Abstract][Full Text] [Related]
35. Circulating microRNA as a Biomarker for Coronary Artery Disease. Fazmin IT; Achercouk Z; Edling CE; Said A; Jeevaratnam K Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32977454 [TBL] [Abstract][Full Text] [Related]
36. Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis. Ormseth MJ; Solus JF; Vickers KC; Oeser AM; Raggi P; Stein CM J Rheumatol; 2015 Oct; 42(10):1746-1751. PubMed ID: 26233505 [TBL] [Abstract][Full Text] [Related]
37. Dysregulated expression of STAT1, miR-150, and miR-223 in peripheral blood mononuclear cells of coronary artery disease patients with significant or insignificant stenosis. Saadatian Z; Nariman-Saleh-Fam Z; Bastami M; Mansoori Y; Khaheshi I; Parsa SA; Daraei A; Vahed SZ; Yousefi B; Kafil HS; Eyvazi S; Ghaderian SMH; Omrani MD J Cell Biochem; 2019 Dec; 120(12):19810-19824. PubMed ID: 31318097 [TBL] [Abstract][Full Text] [Related]
38. Plasma miR-22-5p, miR-132-5p, and miR-150-3p Are Associated with Acute Myocardial Infarction. Li H; Zhang P; Li F; Yuan G; Wang X; Zhang A; Li F Biomed Res Int; 2019; 2019():5012648. PubMed ID: 31179325 [TBL] [Abstract][Full Text] [Related]
39. Alteration in microRNA-155 level correspond to severity of coronary heart disease. Qiu XK; Ma J Scand J Clin Lab Invest; 2018 May; 78(3):219-223. PubMed ID: 29411649 [TBL] [Abstract][Full Text] [Related]
40. MiR-23a Regulates the Vasculogenesis of Coronary Artery Disease by Targeting Epidermal Growth Factor Receptor. Wang S; He W; Wang C Cardiovasc Ther; 2016 Aug; 34(4):199-208. PubMed ID: 27085964 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]